[Monoclonal antibodies against the factor VIII/Willebrand factor molecule: inhibition of the cofactor action of ristocetin and the antihemophilic factor].
Seven hybridoma cell lines secreting antibodies active against the F.VIII/vWF protein, were established. Three of them inhibit ristocetin-induced platelet aggregation, two others are directed against the antihemophilic activity and two bind to the molecule without any effect on biological activities.